| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/14/2008 | US7435412 Using lymphocyte antigen binding profiles to diagnose and treat cancer; antitumor agents |
| 10/14/2008 | US7435410 Methods of treatment with interferson and albumin fusion protein |
| 10/14/2008 | CA2339244C Methods of ophthalmic administration |
| 10/14/2008 | CA2315248C Protein expression in baculovirus vector expression systems |
| 10/14/2008 | CA2237529C Vaccine compositions for intranasal administration comprising chitosan and use thereof |
| 10/12/2008 | CA2629790A1 Use of avian anti-methanogen antibodies for reduction of methane production |
| 10/09/2008 | WO2008121992A2 Attenuated viruses useful for vaccines |
| 10/09/2008 | WO2008121958A1 Use of prrsv vaccines to reduce pcv2 viremia |
| 10/09/2008 | WO2008121940A1 Cxcl13 antagonists and their use for the treatment of inflammatory diseases |
| 10/09/2008 | WO2008121881A2 INHIBITORS OF NF-ϰB ACTIVITY |
| 10/09/2008 | WO2008121876A2 Non-fucosylated antibodies |
| 10/09/2008 | WO2008121821A1 Treatment of hodgkins lymphoma |
| 10/09/2008 | WO2008121797A1 Fxdy5 modulators for treating, diagnosing, and detecting cancer |
| 10/09/2008 | WO2008121615A2 Antibody formulation |
| 10/09/2008 | WO2008121461A2 Vaccine for activating helper function of cd8+ tcells |
| 10/09/2008 | WO2008121406A1 Detection of food specific human igg4 antibodies |
| 10/09/2008 | WO2008121329A2 Turkey herpesvirus vectored recombinant containing avian influenza genes |
| 10/09/2008 | WO2008121146A1 Preventive and therapeutic vaccine for stroke and neurological disorders |
| 10/09/2008 | WO2008121127A2 Methods of use of polycomb homologue mel-18 |
| 10/09/2008 | WO2008121102A2 Hedgehog signaling pathway antagonist cancer treatment |
| 10/09/2008 | WO2008121027A1 Growth stimulating and cell regenerating composition and a method for carrying out said method |
| 10/09/2008 | WO2008121007A1 Novel saratan polypeptides and polynucleotides and methods of use thereof |
| 10/09/2008 | WO2008120202A2 Antibodies, methods and kits for diagnosing and treating melanoma |
| 10/09/2008 | WO2008120101A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 10/09/2008 | WO2008119781A1 A method for improving the manufacturing process of a tumour vaccine |
| 10/09/2008 | WO2008119567A2 Cross-species-specific cd3-epsilon binding domain |
| 10/09/2008 | WO2008119565A2 Cross-species-specific binding domain |
| 10/09/2008 | WO2008119358A2 Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions |
| 10/09/2008 | WO2008119254A1 New use of coccidian |
| 10/09/2008 | WO2008100805A3 Anti-robo4 antibodies and uses therefor |
| 10/09/2008 | WO2008091701A3 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease |
| 10/09/2008 | WO2008085551A3 Smallpox monoclonal antibody |
| 10/09/2008 | WO2008082903A3 Methods for making passive immunotherapies |
| 10/09/2008 | WO2008076157A3 Modified vaccinia ankara virus vaccine |
| 10/09/2008 | WO2008067283A3 Ovr110 antibody compositions and methods of use |
| 10/09/2008 | WO2008067056A3 Method of inhibiting coagulation with human anti-factor va antibodies and use thereof |
| 10/09/2008 | WO2008062288A8 Poly-tlr antagonist |
| 10/09/2008 | WO2008060385A3 Li-key enhanced vaccine potency |
| 10/09/2008 | WO2008054597A3 Tyrosine phosphorylation sites |
| 10/09/2008 | WO2008048675A3 Treatment for age-related macular degeneration and other diseases of the eye |
| 10/09/2008 | WO2008022295A3 Prlr-specific antibody and uses thereof |
| 10/09/2008 | WO2008019131A3 Methods and compositions for treating ige-mediated diseases |
| 10/09/2008 | WO2008019061A3 Anti-il-6 monoclonal antibodies and uses thereof |
| 10/09/2008 | WO2008008463A3 METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPβ |
| 10/09/2008 | WO2007118206A3 Canine influenza virus |
| 10/09/2008 | WO2007112001A3 Compositions and methods for treating myocardial infarction |
| 10/09/2008 | WO2007106072A3 Isolated complexes of endotoxin and modified md-2 |
| 10/09/2008 | WO2007095729A8 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 10/09/2008 | WO2007095151A3 Nerve regeneration employing keratin biomaterials |
| 10/09/2008 | WO2007087289A3 Anti-fcrn antibodies for treatement of auto/allo immune conditions |
| 10/09/2008 | WO2007084740A3 Tat-030 and methods of assessing and treating cancer |
| 10/09/2008 | WO2007076091A3 Treatment of viral infections using a tissue factor inhibitor |
| 10/09/2008 | WO2007003898A8 Process for attaching effector molecules to proteins |
| 10/09/2008 | US20080249288 Recombinantly preparing antibody fusion for targeting and/or treating metabolic disorders |
| 10/09/2008 | US20080249085 for treating cell proliferative diseases; maytansinoid analogs; with lower systemic toxicity, improved pharmacokinetic profile, and better clinical activity; inhibiting fungal growth; compounds can target tubulin, Heat Shock Protein-90 |
| 10/09/2008 | US20080249013 Immunogenic fragment of a Cripto fusion protein that is reactive with an antibody or T-cell that reacts with a given polypeptide sequence; polynucleotides, expression vectors, host cells, T-cell lines; diganosis, prevention, treatment of lung, colon, colorectal and breast cancers |
| 10/09/2008 | US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions |
| 10/09/2008 | US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 10/09/2008 | US20080248531 Preparation of fully human antibodies |
| 10/09/2008 | US20080248529 Expression vector comprising nucleotide sequences coding lymphocyte surface protein specific immunoglobulin for use in treatment of cell proliferative, inflammatory and autoimmune diseases |
| 10/09/2008 | US20080248528 Erythrovirus and its applications |
| 10/09/2008 | US20080248502 Using coxsackie virus and adenovirus receptor (CAR) specific immunoglobulin for treatment and prevention of contact dermatitis |
| 10/09/2008 | US20080248118 Antioxidant superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase hemeoxygenase, acetyl salicyclic acid, mannitol, captopril, Arg, or pyruvate; vitamins(lycopene, lutein, xeaxanthine, Vitamin A, carotene); administered via carotid artery or juguar vein |
| 10/09/2008 | US20080248098 Polysaccharide Microparticles Containing Biological Agents: Their Preparation and Applications |
| 10/09/2008 | US20080248094 Vaccine adjuvant properties of lipsomes formed at elevated temperatures from the polar chloroform extractable lipids from mycobacterium bovis |
| 10/09/2008 | US20080248091 Charge Gradient Inhibition of Trypanosoma Cruzi and Other Parasite's Invasive Action |
| 10/09/2008 | US20080248068 Use of Flagellin as an Adjuvant for Vaccine |
| 10/09/2008 | US20080248067 Immunomodulating Compositions and Uses Therefor |
| 10/09/2008 | US20080248066 Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods using the modified microbes for the activation antigens |
| 10/09/2008 | US20080248065 Gna1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis |
| 10/09/2008 | US20080248064 Localization and Characterization of Flavivirus Envelope Gylcoprotein Cross-Reactive Epitopes and Methods for their Use |
| 10/09/2008 | US20080248063 Hetero-Oligomeric Hiv Envelope Proteins |
| 10/09/2008 | US20080248062 virus-like particles (VLPs) of HPV, said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid. In preferred embodiments, the aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate. |
| 10/09/2008 | US20080248061 vaccine against porcine circovirus type 2 (PCV-)2 and a method for the manufacture of such a vaccine, for protecting piglets against PCV-2 infection. |
| 10/09/2008 | US20080248060 Adenoviral vector-based malaria vaccines |
| 10/09/2008 | US20080248059 Dimensional Analysis of Saccharide Conjugates with Gpc & Sec-Mals |
| 10/09/2008 | US20080248057 Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation |
| 10/09/2008 | US20080248056 Immunomodulatory Product Obtained from a Bifidobacterium Culture and Compositions Containing the Same |
| 10/09/2008 | US20080248055 Using glutamate decarboxylase therapeutic for treatment and prevention of pancreatic disorders |
| 10/09/2008 | US20080248054 Regulation of Mink in Thymocytes and T Lymphocytes |
| 10/09/2008 | US20080248053 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases |
| 10/09/2008 | US20080248052 Vitamin receptor binding drug delivery conjugate |
| 10/09/2008 | US20080248051 Monomethylvaline compounds capable of conjugation to ligands |
| 10/09/2008 | US20080248050 Meta-specific vaccine, method for treating patients immunized with meta-specific vaccine |
| 10/09/2008 | US20080248049 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of leukemia; immunotherapy |
| 10/09/2008 | US20080248048 Interleukin receptor specific immunoglobulin for use in diagnosis, prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary, scleroderma, inflammatory bowel and Hodgkin's diseases |
| 10/09/2008 | US20080248047 Immunoglobulin mixture for use in treatment and prevention of cell proliferative and inflammatory disorders |
| 10/09/2008 | US20080248046 Death domain containing receptor 5 |
| 10/09/2008 | US20080248045 Polypeptides having a triggering nk activity and biological applications |
| 10/09/2008 | US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination |
| 10/09/2008 | US20080248043 Antibodies to SARS coronavirus |
| 10/09/2008 | US20080248042 Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc |
| 10/09/2008 | US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders |
| 10/09/2008 | US20080248040 Nucleotide sequences coding membrane protein segments for use in identifying modulators for prevention and treatment of epilepsy, cancer, pain and sleep disorders |
| 10/09/2008 | US20080248039 Antibodies Against Histone Modifications for Clinical Diagnosis and Prognosis of Cancer |
| 10/09/2008 | US20080248038 Combination of an anti ED-B fibronectin domain antibody and an anti-EGFR-antibody |
| 10/09/2008 | US20080248037 Death receptor-5 (DR-5) specific immunoglobulin for use in treatment and prevention of cell proliferative and immune related disorders |
| 10/09/2008 | US20080248036 Treatment with anti-vegf antibodies |
| 10/09/2008 | US20080248035 Pyrrole derivatives, dyslipidemic agents (cholesteryl ester transfer protein inhibitors), antiobesity agents (serontonin receptor inhibitors), antihyperglycemic agents (insulin sensitizing agents/PPAR agonists), anti-inflammatory agents |
| 10/09/2008 | US20080248034 Using lectin membrane protein specific immunoglobulin to treat, target and prevent cell proliferative disorders |